Hydroxychloroquine, azithromycin prescriptions skyrocket amid early days of COVID-19

Dispensed prescriptions of hydroxychloroquine in the U.S. increased 86.2%, while such prescriptions of chloroquine increased 158.6% from February to March 2020, data show.
The report in JAMA Internal Medicine also showed that the percentage of patients receiving both hydroxychloroquine and azithromycin prescriptions increased 1,044% during the same time period.
Nadine Shehab, PharmD, MPH, of the CDC’s COVID-19 Response Team, and colleagues used information from the IQVIA Total Patient Tracker, a database that compiles initial prescriptions and refills paid for by commercial third parties,

Source link

Related posts

GIQuIC Announces Transition to More Agile Technical Platform for Its Quality Registry


Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress


New ASGE president hopes to expand leadership training, promote innovation


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World